1. Home
  2. ALLT vs BCYC Comparison

ALLT vs BCYC Comparison

Compare ALLT & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allot Ltd.

ALLT

Allot Ltd.

HOLD

Current Price

$7.27

Market Cap

364.0M

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$4.03

Market Cap

310.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLT
BCYC
Founded
1996
2009
Country
Israel
United Kingdom
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
364.0M
310.7M
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
ALLT
BCYC
Price
$7.27
$4.03
Analyst Decision
Strong Buy
Buy
Analyst Count
6
10
Target Price
$12.40
$13.90
AVG Volume (30 Days)
439.7K
542.3K
Earning Date
05-12-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.84
N/A
Revenue Next Year
$12.09
N/A
P/E Ratio
$469.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.12
$3.95
52 Week High
$11.92
$9.18

Technical Indicators

Market Signals
Indicator
ALLT
BCYC
Relative Strength Index (RSI) 47.75 34.52
Support Level $6.98 $3.95
Resistance Level $7.47 $4.75
Average True Range (ATR) 0.32 0.18
MACD -0.03 -0.00
Stochastic Oscillator 46.46 2.63

Price Performance

Historical Comparison
ALLT
BCYC

About ALLT Allot Ltd.

Allot Ltd is a provider of security and network intelligence solutions for mobile, fixed, and cloud service providers, as well as enterprises. It offers network-based security solutions such as mobile security, DDoS protection, and IoT security, along with network analytics and traffic management. It focuses on expanding its Security-as-a-Service (SECaaS) offerings through the Allot Secure product family, which delivers unified protection for consumers and SMBs across mobile, fixed, and 5G networks. Its Allot Smart solutions enable service providers to analyze and manage network data, optimize performance, reduce costs, and enhance user experience. It has a customer base in Europe, which generates maximum revenue, as well as in Asia and Oceania, the Americas, the Middle East, and Africa.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: